Whew! Nice revenue jump. Wish operating profits were higher though.
August 08, 2001
Dow Jones News Service
Vasomedical Inc. - Westbury, N.Y.
4th Quar May 31:
2001 2000
Revenue $8,741,000 $4,521,000
Net income a 6,814,000 b 1,023,000
Avg shrs (basic) 57,068,000 55,746,000
Avg shrs (diluted) 60,299,000 60,948,000
Shr earns (basic)
Net income a .12 b .02
Shr earns (diluted)
Net income a .11 b .02
Year:
Revenue 27,508,000 13,674,000
Net income a 11,694,000 b 1,691,000
Avg shrs (basic) 56,571,000 52,581,000
Avg shrs (diluted) 59,927,000 57,141,000
Shr earns (basic)
Net income a .21 b .03
Shr earns (diluted)
Net income a .20 b .03
Figures in parentheses are losses.
a. Includes a deferred tax benefit of $5.3 million, or 9 cents a share.
b. Includes a deferred tax benefit of $400,000, or 1 cent a share.
Earnings before income taxes for the fourth quarter were $1.6 million, up from $623,000 a year ago.
Vasomedical Inc. (VASO) attributed the increase in revenue in the fourth quarter and year to strong sales of its EECP enhanced external counterpulsation system
used to deliver noninvasive therapy for the treatment of cardiovascular diseases.
The maker of external counterpulsation systems reported $4.9 million in cash, $16.2 million in working capital, and $1.1 million in long-term debt. |
